A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma

DSpace Repository

A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma

Author: Giesen, Nicola; Chatterjee, Manik; Scheid, Christof; Poos, Alexandra M.; Besemer, Britta; Miah, Kaya; Benner, Axel; Becker, Nicole; Moehler, Thomas; Metzler, Ivana; Khandanpour, Cyrus; Seidel-Glaetzer, Andrea; Trautmann-Grill, Karolin; Kortuem, K. Martin; Mueller-Tidow, Carsten; Mechtersheimer, Gunhild; Goeppert, Benjamin; Stenzinger, Albrecht; Weinhold, Niels; Goldschmidt, Hartmut; Weisel, Katja; Raab, Marc S.
Tübinger Autor(en):
Besemer, Britta
Published in: Blood (2023), Bd. 141, H. 14, S. 1685-1690
Verlagsangabe: Amer Soc Hematology
Language: English
Full text: http://dx.doi.org/10.1182/blood.2022017789
ISSN: 0006-4971
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)